CAPLIPOINT
NIFTY500
Caplin Point Laboratories Ltd.
Pharma · NSE
₹1,856.30
1Y-2.4%
52-week range
₹1,500 – ₹2,395
From 52w high
-22.5%
RSI (14)
67.5
vs SMA 50 / 200
↑ 50 · ↓ 200
PE
23.0
Forward PE
20.2
ROE
—
Profit margin
29.3%
D/E
0.17
Dividend yield
0.32%
Quality score
60/100
Revenue growth
10.1%
Earnings growth
18.3%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.